Norman Schwartz - Mar 8, 2024 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO BIOB)

Role
Chairman, President, and CEO, Director, 10%+ Owner
Signature
/s/ Norman Schwartz
Stock symbol
BIO BIOB
Transactions as of
Mar 8, 2024
Transactions value $
$0
Form type
4
Date filed
3/12/2024, 12:23 PM
Previous filing
Dec 7, 2023
Next filing
Aug 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BIO BIOB Bio-Rad A Common Stock 433K Mar 8, 2024 Direct
holding BIO BIOB Bio-Rad B Common Stock 361K Mar 8, 2024 Direct
holding BIO BIOB Bio-Rad B Common Stock 12.9K Mar 8, 2024 By Spouse F1
holding BIO BIOB Bio-Rad B Common Stock 4.06M Mar 8, 2024 By Blue Raven Partners, L.P. F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO BIOB Non-Qualified Stock Option (right to buy) Award $0 +14.1K $0.00 14.1K Mar 8, 2024 Bio-Rad A Common Stock 14.1K $343.76 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of these shares.
F2 The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F3 The stock option vests over four years at 25% per year on the yearly anniversary date of the grant.